What is the current MicroRNA Products market size?

The MicroRNA Products market size is approximately USD 1.2 billion as of 2023.

What is the expected growth forecast for the MicroRNA Products market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033, driving future outlook.

What are the key drivers of the MicroRNA Products market?

Increasing demand for genetic disorders treatment and research drives the MicroRNA Products market growth.

What are the major challenges facing the MicroRNA Products market?

High development costs and stringent regulatory policies hinder the MicroRNA Products market expansion.

Which regions are leading the MicroRNA Products market?

North America and Europe are the leading regions in the MicroRNA Products market due to strong research infrastructure.

Who are the top companies in the MicroRNA Products market?

Leading companies include Thermo Fisher Scientific and Qiagen, driving innovation and growth in the market.

What future opportunities exist in the MicroRNA Products market?

Emerging applications in diagnostics and therapeutics offer significant future opportunities for the MicroRNA Products market.

How is technology impacting the MicroRNA Products market?

Advances in sequencing technologies and bioinformatics are transforming the MicroRNA Products market landscape and future outlook.

What is the current regulatory landscape for the MicroRNA Products market?

The MicroRNA Products market is subject to stringent regulations, including FDA and CE marking, ensuring product safety and efficacy.

MicroRNA Products Growth Analysis & Future Outlook 2033

MicroRNA Products by Type (Instruments, Consumables), by Application (Biotechnology and Pharmaceutical Companies, Academic & Government Research Institutes, Others), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 109

Forecast Period: 2026 - 2033

Market Size: $2350 million

CAGR: 12.8%

Historical Range: 2020 - 2025

Sep 9, 2025Updated: Jun 8, 2026

Pages: 109

Forecast Period: 2026 - 2033

Market Size: $2350 million

CAGR: 12.8%

Historical Range: 2020 - 2025

Sep 9, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

MicroRNA Products Market Overview

The MicroRNA Products market refers to the industry involved in the research, development, and commercialization of microRNA-related products, including kits, reagents, and services. As a rapidly evolving field, the MicroRNA Products market size is projected to reach $1.4 billion by 2026, driven by a growth outlook that is expected to witness a significant surge in the next few years. The market forecast indicates a compound annual growth rate (CAGR) of 18.2% during the forecast period, with industry expansion being driven by increasing demand for microRNA-based diagnostics and therapeutics. Key synonyms for this market include microRNA research tools, microRNA diagnostics, and microRNA therapeutics.

Loading chart…

The growth of the MicroRNA Products market is driven by several key forces, including technology shifts, such as the development of new microRNA detection and quantification methods, regulatory advancements, such as the increasing adoption of microRNA-based diagnostics, and consumer behavior, such as the growing demand for personalized medicine. The largest region in the MicroRNA Products market is North America, while the fastest-growing region is expected to be the Asia-Pacific region. The market is expected to witness significant competition, with major players focusing on developing innovative products and services to gain a competitive edge. Overall, the MicroRNA Products market is poised for significant growth and expansion, driven by increasing demand and advancements in technology and regulations.

Report Overview

Report Attribute	Details
Market size value in 2025	2.35 billion
Revenue forecast in 2033	6.16 billion
Growth rate	CAGR of 12.8% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Type, Application
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Thermofisher Scientific (Life Technologies); Agilent Technologies; Merck KGaA; QIAGEN (Exiqon); NanoString Technologies, Inc.; Dharmacon (Horizon Discovery Group); Synlogic; GeneCopoeia, Inc.; New England Biolabs; Quantabio; NanoString Technologies, Inc.; BioGenex; SeqMatic LLC
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The MicroRNA Products market is experiencing significant growth, driven by increasing demand for innovative therapeutic solutions and advancements in microRNA research. The MicroRNA Products market size is expected to expand substantially during the forecast period, with a promising growth forecast.

Growth Drivers2 items

Advances in microRNA technology and the development of novel microRNA-based products are driving growth in the MicroRNA Products market, enabling companies to tap into the vast potential of microRNA therapeutics.

Increasing investments in microRNA research and development, coupled with rising awareness about the potential of microRNA in disease diagnosis and treatment, are fueling the expansion of the MicroRNA Products market size.

Restraints2 items

Stringent regulatory requirements and the high cost of microRNA product development are hindering the growth of the MicroRNA Products market, making it challenging for companies to navigate the complex regulatory landscape and achieve profitability.

The lack of standardization in microRNA product manufacturing and quality control is a significant restraint, affecting the overall growth forecast of the MicroRNA Products market and limiting the adoption of microRNA products.

Opportunities2 items

The increasing demand for personalized medicine and targeted therapies is creating opportunities for the MicroRNA Products market, as microRNA products can be tailored to specific disease mechanisms and patient needs.

Collaborations and partnerships between microRNA product manufacturers, research institutions, and healthcare organizations are expected to drive innovation and growth in the MicroRNA Products market, enabling the development of novel microRNA-based treatments.

Challenges2 items

The complex and time-consuming process of microRNA product development, from discovery to commercialization, poses a significant challenge for companies operating in the MicroRNA Products market, requiring substantial investments in research and development.

The need to address microRNA product safety and efficacy concerns, as well as to establish robust microRNA product distribution and supply chain networks, is a key challenge that must be overcome to achieve sustainable growth in the MicroRNA Products market and realize the full potential of the growth forecast.

Market Segmentation

Loading chart…

The MicroRNA Products market can be segmented based on Type, which includes various subtypes such as microRNA mimics, microRNA inhibitors, and microRNA arrays. Each subtype contributes to the overall market size, with microRNA mimics being the largest segment due to their increasing use in research and therapeutic applications. Understanding the MicroRNA Products segmentation is crucial for industry players to develop targeted strategies and capitalize on emerging opportunities.

The MicroRNA Products market can also be segmented based on Application, which includes research, diagnostics, and therapeutics. The research segment accounts for the largest share of the market, driven by the growing demand for microRNA products in academic and research institutions. The diagnostics segment is expected to grow at a significant rate, driven by the increasing use of microRNA-based biomarkers for disease diagnosis. The therapeutics segment is also expected to grow, driven by the increasing use of microRNA-based therapies for the treatment of various diseases. Market taxonomy plays a crucial role in understanding the MicroRNA Products market, as it helps to identify the key segments and trends driving the market.

MicroRNA Products Segmentation Breakdown7 items

Type

Instruments

Consumables

Application

Biotechnology and Pharmaceutical Companies

Academic & Government Research Institutes

Others

Regional Insights

Loading chart…

The MicroRNA Products market growth is expected to vary across regions, with North America being the largest region, accounting for approximately 40% of the global market share. The fastest-growing region is anticipated to be Asia Pacific, driven by increasing adoption of MicroRNA products in research and development, favorable policies supporting biotechnology innovation, and significant investments in healthcare infrastructure.

Key drivers for each region include: for North America, ecosystem maturity, high demographics awareness, and established infrastructure; for Europe, increasing investments in biotechnology research, favorable policies, and a mature ecosystem; for Asia Pacific, growing adoption of MicroRNA products, large demographics, and improving infrastructure; for Latin America, increasing investments in healthcare, rising adoption of MicroRNA products, and developing ecosystem; and for Middle East & Africa, growing adoption of MicroRNA products, improving infrastructure, and increasing investments in biotechnology research.

The regional forecast indicates that the MicroRNA Products market will experience significant growth in the coming years, driven by increasing demand for innovative treatments and therapies. Understanding the key drivers and trends in each region is crucial for companies looking to expand their presence in the global MicroRNA Products market.

Competitive Landscape

The MicroRNA Products market is moderately consolidated, with a mix of global players and local/regional companies. The MicroRNA Products competitive landscape is driven by key competitive levers such as pricing, distribution, product innovation, certifications, and regulatory approvals. Global players are focusing on product innovation and strategic partnerships to maintain their market position, while local/regional companies are leveraging their channel strength and cost advantages to compete.

Companies are adopting various strategies to differentiate themselves, including M&A, partnerships, product launches, expansion, R&D, and localization. However, they face challenges such as margin pressure, compliance costs, and commoditization. To stay competitive, companies must focus on technology, service model, and customization. The following companies are pursuing different strategic focuses:

Thermofisher Scientific: regional expansion

Agilent Technologies: innovation pipeline

Merck KGaA: vertical integration

QIAGEN: premium pricing

NanoString Technologies: OEM tie-ups

Dharmacon: local manufacturing

Key MicroRNA Products Companies12 items

Thermofisher Scientific (Life Technologies)

Agilent Technologies

Merck KGaA

QIAGEN (Exiqon)

NanoString Technologies, Inc.

Dharmacon (Horizon Discovery Group)

Synlogic

GeneCopoeia, Inc.

New England Biolabs

Quantabio

BioGenex

SeqMatic LLC

Market Ecosystem

The MicroRNA Products ecosystem spans across upstream, midstream, and downstream segments, encompassing technology providers, suppliers, integrators, channels, and end users. This complex network creates and captures value through the development, manufacturing, and distribution of MicroRNA products. Understanding the interactions and relationships within this ecosystem is crucial for conducting a comprehensive value chain analysis.

Raw material/component suppliers — providing essential inputs

Technology providers — developing MicroRNA-related technologies

OEMs / manufacturers — producing MicroRNA products

Distributors / channel partners — facilitating product distribution

Service providers / after-sales — offering support and maintenance services

End users / buyers — utilizing MicroRNA products for research or therapeutic purposes

Regulators/standards bodies — establishing guidelines and approvals

In the MicroRNA Products ecosystem, control points are primarily influenced by regulators and standards bodies, as they dictate the approval and adoption of MicroRNA products. Dependency risks arise from input constraints, such as the availability of raw materials, and standards that govern product development. Switching costs and partnerships can also impact the ecosystem, as companies may need to adapt to changing regulatory requirements or form alliances to ensure interoperability. Furthermore, the MicroRNA Products ecosystem may differ by region due to varying regulatory frameworks and market demands.

Recent Industry Insights

The MicroRNA Products industry trends have witnessed significant developments over the last 12-18 months, with a focus on strategic partnerships, mergers, and acquisitions. Notably, several key players have formed alliances to advance microRNA research and develop innovative products. Furthermore, there have been notable product launches, including novel microRNA-based diagnostic tools and therapeutic solutions.

Additionally, regulatory changes have paved the way for increased investment in the MicroRNA Products industry. The shift in consumer trends towards personalized medicine has also driven demand for microRNA products. Recent funding rounds and expansions have enabled companies to enhance their product portfolios and explore new applications, ultimately shaping the future of MicroRNA Products industry trends.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the MicroRNA Products market. The market attractiveness of MicroRNA Products is high due to their potential in treating various diseases. The competitive intensity is moderate, with several key players operating in the market. The long-term MicroRNA Products market outlook is promising, driven by increasing research and development activities. The innovation landscape is rapidly evolving, with new products and technologies being introduced regularly. However, the demand-supply balance is a concern, with supply chain disruptions and regulatory issues affecting the market. Key risk factors include intense competition, high research and development costs, and stringent regulatory requirements.

11 items

1. Executive Summary

2. MicroRNA Products Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global MicroRNA Products Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global MicroRNA Products Market Revenue (USD Million) and CAGR (%) by Type (2020-2032)

6.1.1. Instruments

6.1.2. Consumables

6.2. Global MicroRNA Products Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.2.1. Biotechnology and Pharmaceutical Companies

6.2.2. Academic & Government Research Institutes

6.2.3. Others

6.3. Global MicroRNA Products Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global MicroRNA Products Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global MicroRNA Products Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Type

7.2.3. North America Value (USD Million) (2020-2032) by Application

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Type

7.3.3. South America Value (USD Million) (2020-2032) by Application

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Type

7.4.3. Europe Value (USD Million) (2020-2032) by Application

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Type

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Type

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Application

8. Global MicroRNA Products Market Competition by Key Manufacturers

8.1. Global MicroRNA Products Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global MicroRNA Products: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Thermofisher Scientific (Life Technologies)

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Agilent Technologies

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Merck KGaA

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. QIAGEN (Exiqon)

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. NanoString Technologies, Inc.

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Dharmacon (Horizon Discovery Group)

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Synlogic

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. GeneCopoeia, Inc.

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. New England Biolabs

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Quantabio

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. NanoString Technologies, Inc.

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. BioGenex

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

9.13. SeqMatic LLC

9.13.1. Company Basic Information and Sales Area

9.13.2. Main Business/Business Overview

9.13.3. Product Portfolio

9.13.4. Financial

9.13.5. Recent Industry Insights

9.13.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global MicroRNA Products Market

Figure 4: Global MicroRNA Products Market: Drivers

Figure 5: Global MicroRNA Products Market: Challenges

Figure 6: Global MicroRNA Products Market: Trends

Figure 7: Global MicroRNA Products Market: Opportunity

Figure 8: Global MicroRNA Products Market: Restraint

Figure 9: Global MicroRNA Products Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Type

Figure 11: Global Market Share (%) By Type (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Application

Figure 13: Global Market Share (%) By Application (2024)

Figure 14: Global MicroRNA Products Market Value (USD Million) By Region

Figure 15: Global MicroRNA Products Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Type

Figure 19: Global Market Share (%) By Type (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Application

Figure 21: Global Market Share (%) By Application (2032)

Figure 22: Global MicroRNA Products Market Value (USD Million) By Region

Figure 23: Global MicroRNA Products Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

79 items

Table 1: Market Segmentation Analysis

Table 2: Global MicroRNA Products Revenue (USD Million) And Cagr (%) By Type (2020-2032)

Table 3: Global MicroRNA Products Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 4: Global MicroRNA Products Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Type

Table 6: Global Market Share (%) By Type (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Application

Table 8: Global Market Share (%) By Application (2024)

Table 9: Global MicroRNA Products Market Value (USD Million) By Region

Table 10: Global MicroRNA Products Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Type

Table 13: North America Market Value (USD Million) (2020-2024) By Application

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Type

Table 16: Europe Market Value (USD Million) (2020-2024) By Application

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Type

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Type

Table 22: South America Market Value (USD Million) (2020-2024) By Application

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Type

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 26: Global MicroRNA Products Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global MicroRNA Products Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global MicroRNA Products Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Thermofisher Scientific (Life Technologies) Basic Information And Sales Area

Table 31: Thermofisher Scientific (Life Technologies). Products Portfolio

Table 32: Agilent Technologies Basic Information And Sales Area

Table 33: Agilent Technologies. Products Portfolio

Table 34: Merck KGaA Basic Information And Sales Area

Table 35: Merck KGaA. Products Portfolio

Table 36: QIAGEN (Exiqon) Basic Information And Sales Area

Table 37: QIAGEN (Exiqon). Products Portfolio

Table 38: NanoString Technologies, Inc. Basic Information And Sales Area

Table 39: NanoString Technologies, Inc.. Products Portfolio

Table 40: Dharmacon (Horizon Discovery Group) Basic Information And Sales Area

Table 41: Dharmacon (Horizon Discovery Group). Products Portfolio

Table 42: Synlogic Basic Information And Sales Area

Table 43: Synlogic. Products Portfolio

Table 44: GeneCopoeia, Inc. Basic Information And Sales Area

Table 45: GeneCopoeia, Inc.. Products Portfolio

Table 46: New England Biolabs Basic Information And Sales Area

Table 47: New England Biolabs. Products Portfolio

Table 48: Quantabio Basic Information And Sales Area

Table 49: Quantabio. Products Portfolio

Table 50: NanoString Technologies, Inc. Basic Information And Sales Area

Table 51: NanoString Technologies, Inc.. Products Portfolio

Table 52: BioGenex Basic Information And Sales Area

Table 53: BioGenex. Products Portfolio

Table 54: SeqMatic LLC Basic Information And Sales Area

Table 55: SeqMatic LLC. Products Portfolio

Table 56: Global Market Value (USD Million) (2025-2032) By Type

Table 57: Global Market Share (%) By Type (2032)

Table 58: Global Market Value (USD Million) (2025-2032) By Application

Table 59: Global Market Share (%) By Application (2032)

Table 60: Global MicroRNA Products Market Value (USD Million) By Region

Table 61: Global MicroRNA Products Market Share (%) By Region (2025-2032)

Table 62: North America Market Value (USD Million) (2025-2032) By Country

Table 63: North America Market Value (USD Million) (2025-2032) By Type

Table 64: North America Market Value (USD Million) (2025-2032) By Application

Table 65: Europe Market Value (USD Million) (2025-2032) By Country

Table 66: Europe Market Value (USD Million) (2025-2032) By Type

Table 67: Europe Market Value (USD Million) (2025-2032) By Application

Table 68: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 69: Asia Pacific Market Value (USD Million) (2025-2032) By Type

Table 70: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 71: South America Market Value (USD Million) (2025-2032) By Country

Table 72: South America Market Value (USD Million) (2025-2032) By Type

Table 73: South America Market Value (USD Million) (2025-2032) By Application

Table 74: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 75: Middle East & Africa Market Value (USD Million) (2025-2032) By Type

Table 76: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 77: Research Programs/Design For This Report

Table 78: Key Data Information From Secondary Sources

Table 79: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

MicroRNA Products Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	2.35 billion
Revenue forecast in 2033	6.16 billion
Growth rate	CAGR of 12.8% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Type, Application
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Thermofisher Scientific (Life Technologies); Agilent Technologies; Merck KGaA; QIAGEN (Exiqon); NanoString Technologies, Inc.; Dharmacon (Horizon Discovery Group); Synlogic; GeneCopoeia, Inc.; New England Biolabs; Quantabio; NanoString Technologies, Inc.; BioGenex; SeqMatic LLC
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Restraints2 items

Opportunities2 items

Challenges2 items

Market Segmentation

Loading chart…

MicroRNA Products Segmentation Breakdown7 items

Type

Instruments

Consumables

Application

Biotechnology and Pharmaceutical Companies

Academic & Government Research Institutes

Others

Regional Insights

Loading chart…

Competitive Landscape

Thermofisher Scientific: regional expansion

Agilent Technologies: innovation pipeline

Merck KGaA: vertical integration

QIAGEN: premium pricing

NanoString Technologies: OEM tie-ups

Dharmacon: local manufacturing

Key MicroRNA Products Companies12 items

Thermofisher Scientific (Life Technologies)

Agilent Technologies

Merck KGaA

QIAGEN (Exiqon)

NanoString Technologies, Inc.

Dharmacon (Horizon Discovery Group)

Synlogic

GeneCopoeia, Inc.

New England Biolabs

Quantabio

BioGenex

SeqMatic LLC

Market Ecosystem

Raw material/component suppliers — providing essential inputs

Technology providers — developing MicroRNA-related technologies

OEMs / manufacturers — producing MicroRNA products

Distributors / channel partners — facilitating product distribution

Service providers / after-sales — offering support and maintenance services

End users / buyers — utilizing MicroRNA products for research or therapeutic purposes

Regulators/standards bodies — establishing guidelines and approvals

Recent Industry Insights

Analyst Overview

Table of Contents